➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Express Scripts

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 5,661,111

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,661,111
Title: Method for improving plant salt-tolerance
Abstract:A method for improving plant salt-tolerance is described, which comprises treating a plant with an active ingredient comprising at least one compound selected from the group consisting of 5-aminolevulinic acid, a derivative of 5-aminolevulinic acid, a salt of 5-aminolevulinic acid, a salt of derivatives of 5-aminolevulinic acid, and hemins. Furthermore, a salt-tolerant plant is described, wherein the plant is treated with the above-described active ingredient. Moreover, a method for causing recovery of a salt-damaged plant is described, comprising administering the above-described active ingredient to a salt-damaged plant.
Inventor(s): Kuramochi; Hitoshi (Tochigi, JP), Konnai; Makoto (Tochigi, JP), Tanaka; Tohru (Saitama, JP), Hotta; Yasushi (Saitama, JP)
Assignee: Cosmo Research Institute (Tokyo, JP) Cosmo Oil Co., Ltd. (Tokyo, JP)
Application Number:08/561,702
Patent Claims:see list of patent claims

Details for Patent 5,661,111

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Recordati Rare Diseases, Inc. PANHEMATIN hemin POWDER, FOR SOLUTION 101246 1 1983-07-20   Start Trial Cosmo Research Institute (Tokyo, JP) Cosmo Oil Co., Ltd. (Tokyo, JP) 2014-11-28 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.